Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Starton Therapeutics to conduct Phase 1b trial in multiple Myeloma with a global Clinical Research Organization
Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
Starton Therapeutics Inc., a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today entered into a definitive agreement to conduct its Phase 1b trial in multiple myeloma with a global Clinical Research Organization (CRO).
Starton has signed an agreement for a business combination with Healthwell Acquisition Corp. I (NASDAQ:HWEL).
READ
This week, we speak with Will Gray, co-Founder and CEO of New Era Helium and John Lipman, co-CEO and co-Chairman of Roth CH Acquisition V Co. (NASDAQ:ROCL). The two announced a business combination in January that would see New Era become a unique stock representing a resource that is not trading like most other commodities. Most...
At the SPAC of Dawn With the US elections officially one week away, there has been big movement with the conservative quartet of de-SPACs, each of which seem to be riding some amount of retail enthusiasm into the polls. Black Rifle Coffee (NYSE:BRCC) has had the most muted week, but it nonetheless rose about +1%...
At the SPAC of Dawn The final week of October comes in with a busy slate of votes including one extension today and nine more clustered on Thursday and Friday. Both TMT (NASDAQ:TMTC) and Insight (NASDAQ:INAQ) are set to hold completion votes for their combinations with eLong Power and Alpha Modus, respectively. Meanwhile, the SPAC...
Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced. That brings October’s tally to seven IPOs with one more...
At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...